Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 22 points (-0.1%) at 16,065 as of Monday, Dec. 2, 2013, 11:45 AM ET. The NYSE advances/declines ratio sits at 1,030 issues advancing vs. 1,883 declining with 116 unchanged.

The Health Services industry currently sits up 0.1% versus the S&P 500, which is unchanged. Top gainers within the industry include DexCom ( DXCM), up 5.3%, Acadia Healthcare Company ( ACHC), up 5.0%, Varian Medical Systems ( VAR), up 1.1% and Humana ( HUM), up 1.0%. On the negative front, top decliners within the industry include Parexel International Corporation ( PRXL), down 2.7%, and Grifols ( GRFS), down 0.7%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. Mindray Medical International Limited ADR r ( MR) is one of the companies pushing the Health Services industry higher today. As of noon trading, Mindray Medical International Limited ADR r is up $0.66 (1.7%) to $40.47 on light volume. Thus far, 177,664 shares of Mindray Medical International Limited ADR r exchanged hands as compared to its average daily volume of 842,700 shares. The stock has ranged in price between $39.54-$40.48 after having opened the day at $39.67 as compared to the previous trading day's close of $39.81.

Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray, develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. Mindray Medical International Limited ADR r has a market cap of $4.8 billion and is part of the health care sector. The company has a P/E ratio of 21.9, above the S&P 500 P/E ratio of 17.7. Shares are up 21.8% year to date as of the close of trading on Friday. Currently there are 4 analysts that rate Mindray Medical International Limited ADR r a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates Mindray Medical International Limited ADR r as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Mindray Medical International Limited ADR r Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, St Jude Medical ( STJ) is up $0.35 (0.6%) to $58.77 on light volume. Thus far, 419,608 shares of St Jude Medical exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $58.29-$59.00 after having opened the day at $58.52 as compared to the previous trading day's close of $58.42.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems. St Jude Medical has a market cap of $17.2 billion and is part of the health care sector. The company has a P/E ratio of 23.9, above the S&P 500 P/E ratio of 17.7. Shares are up 63.3% year to date as of the close of trading on Friday. Currently there are 10 analysts that rate St Jude Medical a buy, 1 analyst rates it a sell, and 10 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, increase in net income and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full St Jude Medical Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, HCA Holdings ( HCA) is up $0.50 (1.1%) to $46.92 on light volume. Thus far, 680,065 shares of HCA Holdings exchanged hands as compared to its average daily volume of 3.7 million shares. The stock has ranged in price between $46.24-$47.06 after having opened the day at $46.33 as compared to the previous trading day's close of $46.42.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $20.8 billion and is part of the health care sector. The company has a P/E ratio of 14.9, below the S&P 500 P/E ratio of 17.7. Shares are up 53.9% year to date as of the close of trading on Friday. Currently there are 15 analysts that rate HCA Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates HCA Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share and poor profit margins. Get the full HCA Holdings Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, WellPoint ( WLP) is up $1.18 (1.3%) to $94.06 on light volume. Thus far, 814,744 shares of WellPoint exchanged hands as compared to its average daily volume of 2.2 million shares. The stock has ranged in price between $92.89-$94.30 after having opened the day at $92.90 as compared to the previous trading day's close of $92.88.

WellPoint, Inc., a health benefits company, through its subsidiaries, offers network-based managed care plans to large and small employer, individual, Medicaid, and senior markets in the United States. The company operates through three segments: Commercial, Consumer, and Other. WellPoint has a market cap of $27.7 billion and is part of the health care sector. The company has a P/E ratio of 10.1, below the S&P 500 P/E ratio of 17.7. Shares are up 53.7% year to date as of the close of trading on Friday. Currently there are 6 analysts that rate WellPoint a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full WellPoint Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Medtronic ( MDT) is up $0.44 (0.8%) to $57.76 on light volume. Thus far, 1.2 million shares of Medtronic exchanged hands as compared to its average daily volume of 4.0 million shares. The stock has ranged in price between $57.15-$57.83 after having opened the day at $57.32 as compared to the previous trading day's close of $57.32.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $57.3 billion and is part of the health care sector. The company has a P/E ratio of 16.6, below the S&P 500 P/E ratio of 17.7. Shares are up 40.0% year to date as of the close of trading on Friday. Currently there are 6 analysts that rate Medtronic a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and notable return on equity. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Medtronic Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null